Skip to main content
. 2021 Feb 24;2021:8862291. doi: 10.1155/2021/8862291

Table 3.

Recovery and matrix effects of Schisandrol B in plasma and tissues homogenate samples (n = 6).

Samples Conc. (ng/mL) Extraction recovery (mean ± SD) Matric effect (mean ± SD)
Plasma 15 75.55 ± 11.85 103.68 ± 9.77
150 87.72 ± 10.91 110.32 ± 13.18
1500 87.44 ± 11.36 105.71 ± 5.72

Heart 2 78.9 ± 9.10 101.31 ± 8.79
40 76.7 ± 4.40 99.88 ± 3.09
800 75.5 ± 10.70 101.38 ± 14.30

Liver 2 97.89 ± 6.19 106.57 ± 12.41
40 96.03 ± 10.05 114.08 ± 4.92
800 87.79 ± 10.74 107.39 ± 7.02

Spleen 2 83.33 ± 8.40 94.56 ± 12.11
40 91.12 ± 5.47 101.61 ± 9.46
800 79.99 ± 3.04 105.42 ± 2.18

Lung 2 93.19 ± 5.16 107.50 ± 4.81
40 96.52 ± 6.81 95.92 ± 12.51
800 92.41 ± 12.10 99.31 ± 8.43

Kidney 2 86.40 ± 9.95 113.13 ± 3.42
40 91.03 ± 6.55 101.98 ± 3.54
800 86.45 ± 5.00 105.82 ± 1.66

Brain 2 91.30 ± 3.29 90.62 ± 7.57
40 94.26 ± 1.79 93.93 ± 9.74
800 82.60 ± 9.80 96.85 ± 13.33